1. High risk profiles for ischemic adverse events such as A. ST-segment elevation myocardial infarction (STEMI) B. Patients with cardiogenic shock or concomitant severe decompensated heart failure C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy D. Restenosis in stented segments or previous sites of balloon angioplasty 2. Patients who cannot follow allocated DAPT schedule due to the planned surgery or elective procedure within 3 months after the stenting 3. Recent history of major surgery or evident events of gastrointestinal bleeding within 1 month from the procedure 4. Patients on anticoagulation therapy with warfarin or other anticoagulants 5. Life expectancy less than 1 year (such as malignancies or other chronic systemic diseases) 6. Pregnant women 7. Past history of allergy or other contraindications for the following medications/materials: aspirin, clopidogrel, heparin, cobalt chromium, sirolimus

NCT02601157_exc_T8
Condition
ischemic adverse events
NCT02601157_exc_T9
Condition
High risk profiles
NCT02601157_exc_T10
Condition
ST-segment elevation myocardial infarction (STEMI)
NCT02601157_exc_T11
Condition
cardiogenic shock
NCT02601157_exc_T12
Condition
heart failure
NCT02601157_exc_T13
Qualifier
severe
NCT02601157_exc_T14
Qualifier
decompensated
NCT02601157_exc_T15
Scope
A. ST-segment elevation myocardial infarction (STEMI) B. Patients with cardiogenic shock or concomitant severe decompensated heart failure C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy D. Restenosis in stented segments or previous sites of balloon angioplasty
NCT02601157_exc_T16
Scope
High risk profiles for ischemic adverse events
NCT02601157_exc_T17
Condition
Myocardial infarction
NCT02601157_exc_T18
Condition
stent thrombosis
NCT02601157_exc_T19
Drug
antiplatelet therapy
NCT02601157_exc_T20
Scope
Myocardial infarction or stent thrombosis
NCT02601157_exc_T21
Scope
C. Myocardial infarction or stent thrombosis in spite of the maintenance of antiplatelet therapy
NCT02601157_exc_T22
Condition
Restenosis
NCT02601157_exc_T23
Mood
planned
NCT02601157_exc_T24
Procedure
surgery
NCT02601157_exc_T25
Qualifier
elective
NCT02601157_exc_T26
Procedure
procedure
NCT02601157_exc_T27
Scope
surgery or elective procedure
NCT02601157_exc_T28
Temporal
within 3 months after the stenting
NCT02601157_exc_T29
Condition
cannot follow allocated DAPT schedule
NCT02601157_exc_T30
Procedure
major surgery
NCT02601157_exc_T31
Condition
events of gastrointestinal bleeding
NCT02601157_exc_T32
Temporal
within 1 month from the procedure
NCT02601157_exc_T33
Scope
major surgery or evident events of gastrointestinal bleeding
NCT02601157_exc_T34
Procedure
anticoagulation therapy
NCT02601157_exc_T35
Drug
warfarin
NCT02601157_exc_T36
Qualifier
other
NCT02601157_exc_T37
Drug
anticoagulants
NCT02601157_exc_T38
Scope
warfarin or other anticoagulants
NCT02601157_exc_T39
Observation
Life expectancy
NCT02601157_exc_T40
Value
less than 1 year
NCT02601157_exc_T41
Condition
malignancies
NCT02601157_exc_T42
Condition
chronic systemic diseases
NCT02601157_exc_T43
Qualifier
other
NCT02601157_exc_T44
Scope
malignancies or other chronic systemic diseases
NCT02601157_exc_T45
Scope
Life expectancy less than 1 year
NCT02601157_exc_T46
Condition
Pregnant
NCT02601157_exc_T47
Person
women
NCT02601157_exc_T48
Condition
allergy
NCT02601157_exc_T49
Condition
contraindications
NCT02601157_exc_T50
Qualifier
other
NCT02601157_exc_T51
Drug
aspirin
NCT02601157_exc_T52
Drug
clopidogrel
NCT02601157_exc_T53
Drug
heparin
NCT02601157_exc_T54
Drug
cobalt chromium
NCT02601157_exc_T55
Drug
sirolimus
NCT02601157_exc_T56
Scope
aspirin, clopidogrel, heparin, cobalt chromium, sirolimus
NCT02601157_exc_T57
Scope
allergy or other contraindications